AI-powered drug discovery platform using foundation models for molecular design.
About
Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
74Traction
40Team
0Visibility
7Profile
40Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Chai Discovery do?
Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development.
How much funding has Chai Discovery raised?
Chai Discovery has raised a total of $2M in funding.
Where is Chai Discovery headquartered?
Chai Discovery is headquartered in San Francisco, United States.
When was Chai Discovery founded?
Chai Discovery was founded in 2024.
What industry does Chai Discovery operate in?
Chai Discovery operates in Artificial Intelligence, Biotechnology, Drug Discovery, Molecular Design, Foundation Models, NeoLab.
Similar Startups